Publications     News     About    Contact

Solutions & Services

Therapeutic expertise

Why APICES

APICES acknowledged for its role in LOADH Study 
Adherence to oral antineoplastic therapy can shape outcomes in advanced NSCLC, but real-world data is often limited. The prospective LOADH study addresses this gap in Spain, and APICES was acknowledged for supporting key study activities.

We are proud to announce that APICES has been acknowledged for its ongoing collaboration in the LOADH study, an Observational prospective study in Lung Cancer (NSCLC). This acknowledgement was highlighted in the Journal of Cancer Research and Clinical Oncology 2025

APICES has contributed extensively to critical aspects throughout the trial, including start-upcoordination, project managementmonitoringmedical monitoringpharmacovigilancedata managementbiostatistics, and medical writing activities. 

This acknowledgment is a great motivation for the entire APICES team to continue the commitment we bring to every project we collaborate on. We sincerely thank Astrazeneca Spain and Dra. Irene Mangues-Bafalluy for giving us the opportunity to support the study as CRO and for including us acknowledgments. We also congratulate them and all investigators and patients on the LOADH Study progress and results. 

The LOADH study aims to evaluate adherence to oral antineoplastic therapy (OAT) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and its potential relationship with several clinical outcomes. 

For further information about the LOADH Study, please visit: LOADH STUDY 

Get the latest clinical insights delivered to your feed or inbox!

Interview with Oscar Salamanca, CEO of APICES

On integration, change leadership, and strengthening Apices as one unified organization  In a clinical research environment where sponsors value stability, predictability, and quality above all else, organizational change must be approached with care. As APICES...

APICES Acknowledged for its Role in GEOCP-SEOR Study 

APICES Acknowledged for its Role in GEOCP-SEOR Study 

Stage III NSCLC care sits at the intersection of multimodal treatment and real-world constraints. The GEOCP-SEOR population-based study describes how patients are managed across Spain, and APICES was acknowledged for supporting the publication through medical editorial assistance.